The GammaRips weekly briefing — engine state, the latest Lab experiment, and what the pool's outcome data showed. No firehose, no FOMO.
We Use Cookies
We use cookies to enhance your experience, analyze site traffic, and for marketing purposes. By clicking "Accept," you agree to our use of cookies. Read our Privacy Policy.
Today's pool, published 2026-10-16. One out-of-the-money call for every bullish name in the 100 most liquid optionable US stocks.Based on overnight flow from 2026-10-15
GammaRips is a daily options data scanner. The engine runs at 23:00 ET and the whole rule fits in one breath. Start with about 3,500 optionable US stocks. Keep the names that traded 3M or more shares that session and carry 25 or more listed strikes. Rank those by combined chain dollar volume and share volume and take the top 100. Keep the bullish names. Price one out-of-the-money call in each, chosen on contract liquidity. That set is the table below, roughly 40 to 50 contracts. Calls only.
Liquidity decides eligibility, not unusual activity. Flow gives context. It does not decide who gets in. Every bullish name in the top 100 is eligible, and most days more than 50 qualify. A deterministic point-in-time rank (delta band, 60-day momentum, a liquidity demotion) keeps 50, using no outcome data. Note what the rank measures: the most liquid names, then one contract inside each. It is not the most liquid contracts in the market, which would be SPY and QQQ every day.
Liquidity gives you contracts you can get in and out of near the quote. In a study over the 60 trading days ending 2026-08-14, no-fill at the 10:00 ET entry fell from 40.5% on the old flow-first funnel to 6.1% on the liquid universe, on the same tape.
This page is the human-readable view and it is free. The same pool, plus point-in-time features, opportunity surfaces, and a queryable outcome history, is served to AI agents over MCP. Every field is leakage-checked. Nothing here contains information that was not knowable at scan time. Every pool contract is tracked to its real outcome, and the scorecard shows Claude Code trading this pool with real money, every trade. There is no pick on this site: your AI builds the trade plan with you.
Past results. Educational only. Not investment advice.
| Ticker | Score | Move | Flow | Thesis | |
|---|---|---|---|---|---|
| ETN | 10 | 1.6% | $51.9M | ETN BULLISH flow demonstrates aggressive institutional positioning, concentrating substantial premium in call options during a minor technical pullback. This options flow highlights strong structural confidence in the company's power management and data center growth story despite short-term multiple compression across the industrial sector. Risk factor: Continued macro headwinds from rising Treasury yields could further pressure high-multiple industrial equities, temporarily delaying a reversal back to recent highs. | |
| CSCO | 8 | 3.5% | $44.9M | CSCO BULL $120C Nov 20 '26. Institutional options flow aggressively targeted the long-term $120 strike with over $34.4 million in premium, positioning for a major recovery following a temporary 3.5% pullback in the underlying shares. This massive bullish positioning materializes as the stock consolidates near its 200-day moving average, utilizing the dip as an accumulation window for Cisco's multi-year AI-networking and optical hardware upgrade cycles. Risk factor: Slower software-renewal rates or a broader cooling of enterprise IT capital expenditure could delay the anticipated breakout timeline. | |
| ADBE | 8 | 4.1% | $33.4M | ADBE BULL $260C Nov 20 '26. The institutional flow shows significant premium concentration in out-of-the-money calls targeting a recovery, capitalizing on a rotation from capital-intensive infrastructure into cash-rich enterprise software names following hot inflation data. This aggressive call buying suggests anticipation of a near-term trend reversal as the stock attempts to establish a technical bottom after a steep year-to-date decline. Risk factor: Persistent negative sentiment from Wall Street analysts citing competitive pressures from lightweight AI creative tools could limit near-term upside and pressure the underlying spot price. | |
| V | 7 | 2.1% | $17.0M | V BULL $420C Nov 20 '26. The institutional flow shows aggressive positioning in out-of-the-money call options, Concentrating premium over $13.8M as the underlying stock breaks through key moving averages and tests multi-month highs prior to its late-October earnings catalyst. Risk factor: High valuation multiples and macro-driven shifts in global payment volumes could trigger a sudden reversal if upcoming quarterly metrics fail to match elevated street expectations. | |
| UNH | 7 | 2.9% | $72.2M | UNH BULL $420C Nov 20 '26. The institutional flow shows massive premium concentration in long-dated out-of-the-money calls, capturing investor optimism following a definitive Q3 earnings beat and raised full-year guidance. This position targets a sustained recovery above major technical resistance levels as the company's margin-improvement strategy takes hold. Risk factor: Persistent pressure from declining insurance membership and elevated commercial medical utilization trends could cap the stock's upside momentum before reaching the target strike. | |
| TMO | 7 | 4.0% | $15.1M | TMO BULL $730C Nov 20 '26. The institutional flow shows massive premium concentration in out-of-the-money call options, highlighting aggressive positioning ahead of the upcoming Q3 earnings announcement on October 21, 2026. This bullish posture aligns with a broader technical breakout as the underlying spot pushes toward new highs, supported by recent price target upgrades from major investment banks. Risk factor: Any unexpected macro-driven spending pullback in the life sciences sector or a post-earnings 'sell-the-news' reaction represents the primary near-term threat to this high-premium directional exposure. | |
| SHOP | 7 | 2.6% | $27.8M | SHOP BULL $180C Oct 23 '26. The institutional flow shows significant call premium concentration at the $180 strike expiring Oct 23 '26, signaling short-term conviction as the stock climbs toward its multi-month highs. This bullish positioning aligns with a wave of sell-side target upgrades, highlighting strong demand for Shopify's agentic commerce partnerships. Risk factor: The primary risk remains the premium valuation multiple, which leaves the underlying equity susceptible to abrupt profit-taking if broader tech sector volatility spikes before the upcoming earnings release. | |
| PLTR | 7 | 0.7% | $225.9M | PLTR BULL $210C Nov 20 '26. Institutional paper aggressively concentrated premium in far out-of-the-money strikes, positioning for a breakout past the recent 52-week highs and anticipating strong growth numbers ahead of the November earnings release. Risk factor: Elevated valuation multiples near 159x earnings leave the equity highly vulnerable to broader sector profit-taking and macroeconomic contractions. | |
| NVDA | 7 | 2.1% | $921.1M | NVDA BULL $225C Nov 20 '26. Institutional flow heavily concentrated in these long-dated contracts as players capitalize on the recent 2.1% dip to $217.23, positioning for a cyclical rebound and the upcoming Blackwell product ramp. Risk factor: Ongoing macroeconomic pressure, rising Treasury yields, and customer financing concerns at key AI infrastructure providers could delay the anticipated sector recovery. | |
| MSTR | 7 | 3.9% | $165.8M | MSTR BULL $180C Nov 20 '26. Institutional options activity demonstrates a massive accumulation of long-dated upside exposure, focusing heavily on the $180 strike. This aggressive positioning absorbs the temporary noise surrounding MSCI index exclusion risks and positions for a significant resumption of the multi-month momentum trend. Risk factor: The primary threat to this thesis lies in the potential for systematic index-related selling pressure if the exclusion is finalized in November, alongside underlying cryptocurrency volatility. | |
| MRNA | 7 | 4.2% | $98.6M | MRNA BULL $290C Nov 20 '26. Institutional flow is concentrating heavy premium on far out-of-the-money call strikes, catching tailwinds from the stock's recent Nasdaq-100 inclusion and positive clinical trial momentum for its personalized cancer vaccine platform. Risk factor: Extreme valuation multiples and high short interest create a highly volatile backdrop, where any delays or underwhelming details in the upcoming trial data could trigger a swift and severe pullback. | |
| MRK | 7 | 1.5% | $13.0M | MRK BULL $150C Nov 20 '26. Institutional options flow has targeted far out-of-the-money premium well ahead of the late-2026 horizon, positioning for a structural breakout as the stock consolidates in an orderly flag pattern near its highs. This bullish concentration aligns with anticipation surrounding upcoming ESMO pipeline presentations and Merck's newly unveiled ADVANCE clinical research facility. Risk factor: Clinical trial data deviations or setback announcements in the core oncology pipeline could rapidly invalidate the breakout thesis. | |
| META | 7 | 0.6% | $571.1M | META BULL $800C Nov 20 '26. The substantial flow premium concentrated at this deep out-of-the-money strike highlights long-term institutional confidence in Meta's ability to monetize its expanding AI architecture, despite near-term headwinds from elevated capital expenditures and regulatory costs. Risk factor: Unexpected margin compression or lower-than-projected fourth-quarter guidance during the upcoming earnings call could stall technical recovery back toward the 52-week high. | |
| MA | 7 | 2.2% | $15.1M | MA BULL $620C Nov 20 '26. The institutional flow shows significant accumulation of long-term upside premium following the launch of Mastercard's Global Money Platform and a bullish price target increase to $730 by Bernstein. This volume suggests high confidence in the firm's stablecoin and payment-rail expansion ahead of its Q3 earnings print on October 29. Risk factor: A macro-driven reversal in the broader Financial Services sector or unexpected regulatory headwinds surrounding stablecoin integrations could temper the stock's near-term momentum. | |
| LLY | 7 | 3.7% | $119.1M | LLY BULL $1300C Nov 20 '26. The institutional flow shows massive premium concentration in long-dated out-of-the-money calls, driven by the positive European regulatory recommendation for its oral weight-loss drug Foundayo. This flow aligns with a broader defensive rotation into dominant healthcare leaders amid a supportive, low-volatility market structure. Risk factor: The primary uncertainty lies in the potential for higher patient discontinuation rates in clinical weight-loss data and upcoming competitive oral clinical trials from rivals. | |
| JNJ | 7 | 0.0% | $44.1M | JNJ BULL $257.5C Oct 23 '26. Institutional flow is targeting a rapid tactical rebound following a post-earnings selloff that was disproportionate to the firm's fundamental performance, as indicated by a massive block of premium concentrating in out-of-the-money weekly calls. The catalyst for this positioning is a market overreaction to a minor Q3 MedTech revenue miss, which overshadowed a strong pharmaceutical performance and raised full-year guidance. Risk factor: Persistent negative sentiment surrounding decelerating medical device sales and ongoing talc-related litigation charges could cap near-term upside and delay the expected technical breakout. | |
| CRM | 7 | 4.5% | $24.6M | CRM BULL $260C Nov 20 '26. The institutional flow shows significant premium concentration in long-dated out-of-the-money calls following a powerful analyst double upgrade and key AI product launches, which reflects growing confidence in the monetization path of Agentforce. This positioning suggests that large-scale participants are targeting a breakout past the current multi-month consolidation range as valuation discounts relative to the peer software sector begin to close. Risk factor: Potential deceleration in core seat-based software licensing revenue or broader enterprise software pullbacks could delay the anticipated expansion. | |
| COIN | 7 | 5.2% | $77.5M | COIN BULL $210C Nov 20 '26. The flow shows a significant concentration of long-term bullish premium targeting an out-of-the-money strike, catalyzed by a newly announced stablecoin payment partnership with Marqeta and anticipation of the upcoming Q3 earnings. This aggressive positioning reflects institutional accumulation following a period of year-to-date consolidation. Risk factor: Elevated volatility in underlying digital asset trading volume and broader crypto market spot price corrections remain key uncertainties that could stall upward momentum. | |
| CLS | 7 | 2.8% | $30.1M | CLS BULL $360C Nov 20 '26. The institutional options flow reveals a high-conviction directional wager as premium concentrates heavily in long-dated, out-of-the-money calls, establishing a strong bullish posture despite a recent -2.8% slide in the underlying spot price to $315.25. This positioning anticipates that secular AI tailwinds and structural datacenter spending will override near-term margin anxieties following the upcoming late-October earnings report and investor day. Risk factor: Persistent insider selling and broader technology hardware multiple contraction could delay the recovery and cap near-term upward price momentum. | |
| AMGN | 7 | 1.9% | $48.9M | AMGN BULL $450C Nov 20 '26. The institutional flow shows aggressive positioning targeting a further breakout beyond its 52-week high, catalyzed by strong clinical pipeline updates and anticipation ahead of its November earnings release. Risk factor: potential structural resistance near the psychological $450 mark and macroeconomic pressure on biotech valuations. | |
| ACN | 7 | 4.6% | $90.4M | ACN BULL $240C Nov 20 '26. The institutional flow displays aggressive premium allocation targeting the $240 strike, positioning for a sustained breakout following Accenture's robust Q4 earnings beat and its newly outlined $8 billion acquisition strategy for fiscal 2027. This directional posture reflects confidence that enterprise AI adoption will generate massive cloud modernization tailwinds over the next year. Risk factor: Integration hurdles and regulatory delays surrounding its high-volume acquisition strategy could slow the anticipated margin expansion. | |
| ABBV | 7 | 0.3% | $78.5M | ABBV BULL $290C Nov 20 '26. Institutional positioning focused heavily on the out-of-the-money $290 strike call options expiring in late November, reflecting strong conviction in the stock's upward momentum following stellar Phase 3 AFFIRM clinical data for subcutaneous Skyrizi and recent FDA breakthrough designations. Risk factor: potential sector rotation out of defensive biopharma and back into mega-cap tech, or unexpected regulatory hurdles for pipeline candidates under FDA review. | |
| SOFI | 6 | 5.9% | $28.4M | SOFI institutional options flow is concentrating heavily on bullish premium near key support levels as the stock attempts to secure a technical bottom at its 52-week low. This aggressive flow appears to be an anticipatory play positioning for a potential shift in momentum ahead of the company's October 27 earnings release. Risk factor: Persistent downward pressure from recent analyst downgrades, insider selling filings, and regulatory headwind concerns could cap near-term recovery attempts. | |
| SNPS | 6 | 2.7% | $14.4M | SNPS BULL $487.5C Oct 23 '26. The institutional flow shows significant premium concentration in short-term, out-of-the-money call options, suggesting high-conviction positioning for a near-term rebound following a mild -2.7% dip fueled by routine insider selling. This bullish positioning aligns with the stock's broader technical support near its 200-day moving average and positive long-term momentum in the technology sector. Risk factor: potential headwinds from broader semiconductor sector volatility or broader market consolidation in a high-valuation environment. | |
| QCOM | 6 | 2.6% | $24.5M | QCOM BULL $200C Nov 20 '26. The institutional flow shows significant accumulation in far out-of-the-money calls, concentrating $15.8M in premium as the market absorbs the positive legal framework established by the Delaware jury verdict against Arm Holdings. This legal victory, combined with structural tailwinds from a $60B AI partnership with Amazon, positions Qualcomm to potentially reduce royalty overhead and expand its market share in the AI and automotive segments. Risk factor: The primary uncertainty lies in the upcoming bench trial rulings by the Delaware federal judge, who will ultimately decide the exact scope of the licensing remedies and royalty suspensions. | |
| NOW | 6 | 5.6% | $39.3M | NOW BULL $160C Nov 20 '26. Institutional options positioning exhibits a strong bullish bias as market participants focus heavily on long-dated out-of-the-money call options, sparked by multiple investment bank upgrades and rising price targets tied to generative AI growth. The underlying spot price of $148.57 reflects rising optimism around ServiceNow's enterprise SaaS dominance and its pending earnings release. Risk factor: Potential volatility and sector pullback in high-valuation enterprise software names if near-term AI monetization metrics or quarterly remaining performance obligations do not exceed elevated expectations. | |
| NFLX | 6 | 1.7% | $45.5M | NFLX BULL $75C Nov 20 '26. The institutional flow shows aggressive call accumulation focusing on the post-earnings horizon, coinciding with major corporate restructuring including 1,000 job cuts and a high-profile leadership transition in its content division. This suggests smart money is positioning for improved operating margins and cost-discipline execution as the company targets $3 billion in 2026 ad revenue. Risk factor: Heightened near-term volatility from the upcoming October 20 earnings release and decelerating domestic viewership growth. | |
| MU | 6 | 1.0% | $2.3B | MU BULL $1050C Nov 20 '26. The institutional flow shows highly aggressive long-term accumulation, concentrating substantial premium at the out-of-the-money $1050 strike expiring in late 2026, which signals high confidence in Micron's structural growth cycle and its capability to clear near-term Chinese competition headwinds. This massive position is established as the stock retests key technical support levels near its 200-day moving average amidst broader semiconductor industry consolidation. Risk factor: Heightened volatility from macroeconomic policy changes, capital spending constraints, and accelerated domestic DRAM production capabilities by foreign competitors could delay the recovery timeline. | |
| MSFT | 6 | 0.6% | $172.0M | MSFT BULL $560C Nov 20 '26. Institutional flow focused heavily on this long-term call strike, absorbing a massive $135.89 million in premium even as near-term headlines focused on a U.K. regulatory probe and cloud switching barriers. The size and positioning of the trade highlight a long-term bullish outlook tied to Azure cloud expansion, highlighted by Microsoft's recent 1,100 megawatt power deal to secure critical AI data center infrastructure. Risk factor: Increased regulatory scrutiny from European and British watchdogs could temporarily compress multiples and introduce operational friction ahead of the October 28 earnings report. | |
| JPM | 6 | 0.1% | $66.3M | JPM BULL $350C Nov 20 '26. The institutional flow displays highly concentrated long-term premium targeting an out-of-the-money strike, catalyzed by a post-earnings valuation upgrade to Buy from Freedom Broker and raised full-year net interest income guidance to $106.2 billion. Risk factor: CEO Jamie Dimon's keyman succession risk and potential headwinds from sticky inflation causing elevated capital market volatility. | |
| IONQ | 6 | 7.9% | $15.7M | IONQ BULL $40C Nov 20 '26. The institutional flow shows significant premium concentration targeting the $40 strike, which aligns exactly with the pricing of the company's massive $2.0 billion equity offering and represents a key psychological magnet. This aggressive, long-dated position suggests high conviction that the underlying equity will recover its post-dilution losses as the market digests the expanded balance sheet strength and the Cambridge Quantum Innovation Centre launch. Risk factor: Persistent shareholder dilution from the massive warrant overhang and integration risks associated with the recent Elisity acquisition could limit the stock's near-term upside velocity. | |
| HOOD | 6 | 1.9% | $122.9M | HOOD BULL $120C Nov 20 '26. The institutional flow demonstrates significant long-term accumulation, concentrating heavily in out-of-the-money calls as the company gains market traction from its newly launched AI trading features, prediction markets, and active trader tools ahead of Q3 earnings. This positioning reflects robust anticipatory conviction in HOOD's fundamental shift toward a comprehensive global financial ecosystem. Risk factor: Broader market equity volatility and potential regulatory scrutiny surrounding prediction markets or AI agent features could trigger temporary pullbacks. | |
| HD | 6 | 4.4% | $27.7M | HD BULL $320C Nov 20 '26. The institutional flow shows massive premium concentration in long-dated out-of-the-money calls, capturing a shift in investor sentiment as a rotation into beaten-down consumer retail names coincides with defensive pro-market expansion. This significant positioning is highly anticipatory of a broader macroeconomic turnaround and a subsequent rebound in housing turnover. Risk factor: Sustained pressure from elevated mortgage rates could continue to suppress large-scale home remodeling demand, delaying the expected fundamental inflection needed to reach the strike. | |
| CVX | 6 | 1.2% | $12.3M | CVX BULL $230C Nov 20 '26. Large-scale institutional call buying has materialized in the deep out-of-the-money $230 strike contract expiring in late 2026, capturing over $10.7M in premium as the underlying spot trades near $219.32. This accumulation pattern signals a major longer-term directional wager that aligns with a string of positive Wall Street rating upgrades and robust structural cash flows. Risk factor: Sudden shifts in crude oil price volatility and broader global supply dynamics could alter the underlying equity's trajectory and erode premium prior to the target horizon. | |
| CRWV | 6 | 3.5% | $340.5M | CRWV BULL $80C Nov 20 '26. The institutional flow shows massive premium concentration in long-term upside calls, capitalizing on the steep discount after credit-market anxieties and 15% bond yields drove a 25% weekly selloff in the equity. This positioning indicates a strong institutional bet that the data-center funding crisis is overblown and a sharp technical rebound is on the horizon. Risk factor: Continued expansion of credit default swaps and rising capital costs could further delay the recovery of highly leveraged AI infrastructure names. | |
| CRCL | 6 | 7.5% | $28.3M | CRCL BULL $95C Nov 20 '26. Institutional flow is positioning heavily in far-dated, out-of-the-money upside calls as the company launches its USDC expansion into 40 emerging markets and prepares for its upcoming Q3 earnings report. This massive $19.3M premium concentration suggests long-term institutional accumulation ahead of potential regulatory catalysts like the U.S. Genius Act in early 2027. Risk factor: Continued downward pressure on stablecoin Treasury reserve yields from falling interest rates could compress core margins and delay the anticipated growth trajectory. | |
| BRK.B | 6 | 0.0% | $17.3M | BRK.B BULL $540C Nov 20 '26. The institutional options flow exhibits aggressive call buying focused at the out-of-the-money strike, tracking alongside market enthusiasm for Berkshire's newly revealed $930 million stake in technology firm Bending Spoons. This shift in capital allocation strategy provides a fresh narrative for the conglomerate as it approaches its next earnings release. Risk factor: unexpected volatility in Berkshire's broader equity investment portfolio or a sudden slowdown in its core insurance underwriting businesses. | |
| XOM | 5 | 1.4% | $13.3M | XOM BULL $180C Nov 20 '26. The institutional flow reflects large premium concentration in out-of-the-money calls targeting new highs, fueled by preliminary guidance showing a massive $4.5 billion refining profit boost that outpaced upstream price drag. The underlying stock is pressing critical resistance levels as analysts step in to raise targets. Risk factor: Near-term crude price volatility and refining margin adjustments prior to the official October 30 earnings call could introduce short-term headwinds. | |
| WMT | 5 | 1.7% | $26.8M | WMT BULL $125C Nov 20 '26. The institutional flow demonstrates significant long-term conviction, concentrating heavy premium in deep out-of-the-money call options following a bullish upgrade from Deutsche Bank that highlighted strong margin growth in digital marketplace and advertising segments. The underlying stock is finding strong institutional support as macro tailwinds favor defensive retail share-gainers. Risk factor: Potential margin pressure from rising supply chain or holiday promotional costs could limit the speed of the expansion toward the strike price. | |
| UBER | 5 | 2.6% | $12.2M | UBER BULL $75C Nov 20 '26. Institutional call buying concentrated heavily at the $75 strike, signaling strong conviction that the equity will break out of its current trading range following a series of highly optimistic analyst reiterations and a $125 price target from Guggenheim. This options layout reflects positioning for sustained upside momentum as the market begins to price in Uber's robust 2027 gross bookings forecasts. Risk factor: Heightened volatility or regulatory hurdles surrounding the rapid expansion of autonomous vehicle programs could disrupt the positive sentiment. | |
| MCD | 5 | 1.7% | $30.2M | MCD BULL $250C Nov 20 '26. The institutional flow indicates long-term conviction targeting a multi-month recovery to key moving averages as the stock attempts to secure a structural bottom around its 52-week lows. This substantial premium accumulation focuses on an out-of-the-money strike, tracking the early stages of a technical rebound and rotational interest into depressed consumer staple names. Risk factor: Near-term margin compression and downward revisions to earnings estimates ahead of the November 4, 2026 earnings report could disrupt this recovery trajectory. | |
| KO | 5 | 0.2% | $8.6M | KO BULL $92.5C Nov 20 '26. The institutional flow shows significant premium concentration in the out-of-the-money November calls, highlighting strong conviction following the major exclusive partnership win with KFC and a target upgrade to $98 by Barclays. This positioning captures a structural growth catalyst and defensive rotation ahead of the company's upcoming late-October earnings report. Risk factor: Potential near-term valuation resistance as the stock trades at a premium relative to its historical intrinsic valuation metrics. | |
| GOOGL | 5 | 0.1% | $120.1M | GOOGL BULL $360C Nov 20 '26. The institutional options flow reveals a concentrated accumulation of out-of-the-money premium ahead of the company's October 28 earnings, heavily fueled by Evercore ISI's optimistic projections regarding Google's Tensor Processing Unit sales and enterprise cloud expansion. This position targets a strike roughly 3% above current trading levels, indicating strong institutional confidence in a post-earnings breakout. Risk factor: Elevated capital expenditure requirements for AI data centers and ongoing antitrust litigation headwinds could introduce near-term volatility that caps the stock's upward trajectory. | |
| VST | 4 | 1.4% | $14.6M | VST BULL $175C Nov 20 '26. The institutional flow shows aggressive positioning in long-dated upside contracts, targeting a significant recovery toward previous highs as the company redeems high-coupon preferred equity and progresses toward major government-backed nuclear expansions. Risk factor: Extreme valuation multiples relative to historical utility peers may cap the upward momentum if power demand forecasts from tech hyperscalers scale back. | |
| NKE | 4 | 5.3% | $17.6M | NKE BULL $37.5C Nov 20 '26. The flow shows institutional buyers stepping in to target near-the-money upside, concentrating substantial premium in the November 2026 contracts as the stock catches a strong bid from a broader sector rotation out of technology and into heavily discounted consumer discretionary names. This aggressive positioning targets a continuation of the near-term momentum as the market begins pricing in a slow-brewing turnaround under the veteran leadership of Elliott Hill. Risk factor: Nike continues to face weak organic demand and fierce competition from rivals like Adidas and On Holding, meaning any failure to show operational improvement in upcoming quarters could quickly stall this recovery rally. | |
| NBIS | 4 | 0.1% | $312.1M | NBIS BULL $230C Nov 20 '26. The institutional flow shows significant accumulation of long-term upside exposure following a sharp sector-wide pullback triggered by capital expenditure and overcapacity concerns across the AI infrastructure landscape. This premium concentration targets a substantial recovery above the current spot price, relying on long-term capacity contracted cash flows through 2028 and strong sequential revenue growth to revitalize momentum. Risk factor: Broad market rotation out of high-multiple, cash-flow-negative neocloud stocks could delay the expected recovery timeline. | |
| IBM | 3 | 2.4% | $18.2M | IBM BULL $250C Nov 20 '26. The institutional flow shows significant premium concentration in out-of-the-money calls expiring after the upcoming Q3 earnings print, capturing a shift in sentiment following a major price target increase from Morgan Stanley. This positioning indicates strong expectation of a technical breakout driven by stabilizing enterprise cloud and AI infrastructure demand. Risk factor: The primary risk remains execution headwind in the consulting division and high valuation multiples leading to potential downside volatility if software recurring revenue metrics fall short of updated guidance. |
The table is ordered by the scan score. That score is descriptive context. It is not a quality rank and it is not a forecast.
A sample from the last few sessions. Each one links to its options-flow breakdown.